Mizuho cuts Amylyx Pharmaceuticals target price to $38 from $42
AMLX•Mizuho cut its target price for Amylyx Pharmaceuticals to $38 from $42.
Related News
FTI Consulting Q3 2026 net income falls 23% to $63.45 million
FCN•
DoorDash strikes $17 billion deal for US rival Instacart
CART•
Belden swings to Q3 2026 net loss of $11.35 million
BDC•
Shell and Total post highest quarterly profit since 2022
TTE•
Monro swings to Q2 FY27 net loss of $1.61 million; sales fall to $283.64 million
MNRO•